Abiopharma

We are an early stage commercial healthcare company engaged in the development of next generation mobile and e-health solutions and monitoring service platforms. Our solutions and services can empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (CVD), pulmonary disease and diabetes. Using our suite of devices, software solutions, algorithms and monitoring services, we are currently driving recurring revenues in the following markets: B2B: professional healthcare markets (including hospitals, clinics and senior care facilities); and B2B2C and B2C: consumer healthcare market. Our Monitoring Services : our operation in the United States which is our main activity provides arrhythmia monitoring services in the professional healthcare market, and vital signs services in the business-to-business (B2B) and business-to-consumer (B2C) concierge medicine and chronic care management markets. Product Lines: Our product lines consist of our Prizma Medical Smartphone Case, or Universal Prizma, 3 in 1 patch monitoring technology capabilities that includes Extended Holter, Event and near real time monitoring . Our products are using our proprietary algorithms, embedded software, frontend and backend software. Our Strategy: our strategic objective is to develop and commercialize innovative next generation M-health and Digital-health solutions and monitoring service platforms. Using our proprietary suite of devices and software solutions we intend to drive multiple and recurring revenue streams, across consumer and professional healthcare verticals and in a variety of geographical territories.

Additional info from OTC:
We are an early stage commercial healthcare company engaged in the development of next generation mobile and e-health solutions and monitoring service platforms. Our solutions and services can empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (CVD), pulmonary disease and diabetes. Using our suite of devices, software solutions, algorithms and monitoring services, we are currently driving recurring revenues in the following markets: B2B: professional healthcare markets (including hospitals, clinics and senior care facilities); and B2B2C and B2C: consumer healthcare market. Our Monitoring Services : our operation in the United States which is our main activity provides arrhythmia monitoring services in the professional healthcare market, and vital signs services in the business-to-business (B2B) and business-to-consumer (B2C) concierge medicine and chronic care management markets. Product Lines: Our product lines consist of our Prizma Medical Smartphone Case, or Universal Prizma, 3 in 1 patch monitoring technology capabilities that includes Extended Holter, Event and near real time monitoring . Our products are using our proprietary algorithms, embedded software, frontend and backend software. Our Strategy: our strategic objective is to develop and commercialize innovative next generation M-health and Digital-health solutions and monitoring service platforms. Using our proprietary suite of devices and software solutions we intend to drive multiple and recurring revenue streams, across consumer and professional healthcare verticals and in a variety of geographical territories.